JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M704942200 on August 28, 2007

J. Biol. Chem., Vol. 282, Issue 43, 31477-31483, October 26, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/43/31477    most recent
M704942200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meier, R.
Right arrow Articles by Baumann, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meier, R.
Right arrow Articles by Baumann, U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Calcium-gated Lid and a Large beta-Roll Sandwich Are Revealed by the Crystal Structure of Extracellular Lipase from Serratia marcescens*Formula

Reto Meier{ddagger}, Thomas Drepper§, Vera Svensson§, Karl-Erich Jaeger§1, and Ulrich Baumann{ddagger}2

From the {ddagger}Department of Chemistry and Biochemistry, University Bern Freiestrasse 3, CH-3012 Bern, Switzerland and §Institute of Molecular Enzyme Technology, Heinrich-Heine-University Duesseldorf, Research Centre Juelich, D-52426 Jülich, Germany

Received for publication, June 15, 2007 , and in revised form, July 20, 2007.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Lipase LipA from Serratia marcescens is a 613-amino acid enzyme belonging to family I.3 of lipolytic enzymes that has an important biotechnological application in the production of a chiral precursor for the coronary vasodilator diltiazem. Like other family I.3 lipases, LipA is secreted by Gram-negative bacteria via a type I secretion system and possesses 13 copies of a calcium binding tandem repeat motif, GGXGXDXUX (U, hydrophobic amino acids), in the C-terminal part of the polypeptide chain. The 1.8-Å crystal structure of LipA reveals a close relation to eukaryotic lipases, whereas family I.1 and I.2 enzymes appear to be more distantly related. Interestingly, the structure shows for the N-terminal lipase domain a variation on the canonical {alpha}/beta hydrolase fold in an open conformation, where the putative lid helix is anchored by a Ca2+ ion essential for activity. Another novel feature observed in this lipase structure is the presence of a helical hairpin additional to the putative lid helix that exposes a hydrophobic surface to the aqueous medium and might function as an additional lid. The tandem repeats form two separated parallel beta-roll domains that pack tightly against each other. Variations of the consensus sequence of the tandem repeats within the second beta-roll result in an asymmetric Ca2+ binding on only one side of the roll. The analysis of the properties of the beta-roll domains suggests an intramolecular chaperone function.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Lipases (EC 3.1.1.3) hydrolyze the ester bonds of long-chain acylglycerides (1). Biotechnologically, they have gained considerable importance as biocatalysts that are able to catalyze not only hydrolysis but also synthesis reactions, with the latter occurring in nearly water-free organic solvents (see Refs. 2 and 3 for detailed reviews) and often with high regio- and enantioselectivity (4). Virtually all of the technologically employed lipases are of microbial origin, because the respective genes are relatively easy to access and can efficiently be expressed. Consequently, it is a lipase produced by the Gram-negative bacterium Pseudomonas aeruginosa that currently constitutes the best studied example of creating an enantioselective enzyme by directed evolution (5-7). A characteristic feature to distinguish lipases from esterases is called interfacial activation and describes the observation that lipase activity sharply increases as soon as the monomolecular substrate starts to form a micellar emulsion (8). An obvious explanation was provided by several lipase crystal structures that revealed the presence of a surface-exposed {alpha}-helical polypeptide chain termed the "lid" which covers the active site and moves away upon contact with the micellar substrate interface (9, 10). However, exceptions have also been observed of lipases that possess a lid and still do not show interfacial activation. Therefore, lipases are presently defined as carboxylesterases catalyzing the hydrolysis of long-chain (>10 carbon atoms) acylglycerols (11).

A classification of bacterial lipases was first put forward by Arpigny and Jaeger (12), who defined eight families (I-VIII) based on amino acid sequences and biological properties. The largest family I is further subdivided in seven subfamilies (I.1-I.7) with the first three subfamilies comprising true lipases from Gram-negative bacteria. All lipases are members of the{alpha}/beta hydrolase superfamily, where the canonical fold comprises a mostly parallel, central eight-stranded beta-sheet. The active site carries the Ser-His-Asp/Glu catalytic triad, where the serine residues are usually located within a characteristic GXSXG motif, which forms a sharp {gamma}-like turn between a beta-strand and the following {alpha}-helix (13).

Although lipases of families I.1 and I.2 are clearly homologous with amino acid sequence identities above 30%, the family I.3 enzymes exhibit only a very low sequence similarity to the former two families. Also, they are translocated to the extracellular medium by a different mechanism. Whereas family I.1 and I.2 lipases are secreted by a type II secretion system (T2SS,3 also named general secretory pathway) (14-16), the family I.3 lipases are transported by a type I secretion system (T1SS) (16-18). This secretion pathway utilizes a C-terminal, non-cleavable secretion signal, and translocation occurs in one step from the cytoplasm to the extracellular medium without the occurrence of periplasmic intermediates. The Escherichia coli hemolysin secretion system Hly constitutes the paradigm of a T1SS (19), which like the other T1SSs consists of three membrane-associated proteins; that is, an inner membrane ABC transporter (HlyB), an outer membrane protein (TolC), and a periplasmic membrane fusion protein (HlyD). T1SS passenger proteins possess as a characteristic feature a variable number of tandem repeats of a glycine-rich nine-residue motif (GGXGXDX(U)X)n (U, apolar residue) that precedes the C-terminal secretion signal. The number n of the repeats correlates positively with the molecular weight of the protein. This so-called RTX signature (repeats in toxins) (20) is responsible for Ca2+ binding. X-ray crystallographic analyses of serralysin-type metalloproteases showed that these repeats fold into a parallel beta-roll, where the first six amino acids build a turn that forms two half-sites for Ca2+ binding, and the remaining three residues fold into a short beta-strand (21-23). The calcium ions bridge the spatially adjacent aspartic acids (position 6 in the motif) from two sequence motifs 18 residues apart. The nonpolar amino acids (abbreviated U) at position 8 build the hydrophobic core of the beta-roll. This peculiar structure is unstable in the absence of Ca2+ but does fold spontaneously in the presence of calcium concentrations in the mM range (24, 25).

Serratia marcescens SM6 produces an extracellular lipase LipA that has been a subject of research for more than 30 years. Its production was found to be stimulated up to 100-fold when the standard growth medium was supplemented with various polysaccharides like glycogen or hyaluronate (26). Later it was shown that this enzyme is a family I.3 lipase of 613 amino acids in length (27). The catalytic residue Ser207 is located in a conserved GHSLGG motif. From inspection of the sequence, S. marcescens LipA possesses about 12-14 repeats of the glycine-rich sequence motif that come in two blocks spanning residues 369-418 and 489-564. Furthermore, S. marcescens LipA is a biotechnologically very important enzyme as it serves for the large-scale kinetic resolution of racemic 3-(4'-methoxyphenyl)glycidic acid methyl ester. LipA catalyzes the enantioselective hydrolysis of the (2S,3R) enantiomer, which is then easily separated from the desired (2S,3R) enantiomer (28). This biocatalytic reaction reduces by 4 steps the original 9-step chemical synthesis to yield diltiazem, a calcium-channel blocker and coronary vasodilator produced worldwide in an excess of 100 t a-1 (29).

Presently, crystal structures have not been reported for S. marcescens LipA nor for any other lipase of family I.3 despite ongoing work (30). Furthermore, homology modeling would be unreliable because the lipase domain of LipA shows only a very limited sequence identity (<20%) to other known lipase structures. Therefore, we have determined the high resolution crystal structure of LipA from S. marcescens.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Protein Expression and Purification—The LipA expression construct was made by cloning the PCR product derived from S. marcescens genomic library into the NdeI and HindIII cloning sites of the pET28a vector (Novagen) using the primers 5'-GGAATTCCATATGGGCATCTTTAGCTATAAGG-3' and 5'-CCCAAGCTTTTAGGCCAACACCACCTGATCGG-3'. The respective restriction sites within the primer sequences are underlined.

LipA was expressed in E. coli BL21 (DE3) cells (Stratagene). Cells were grown at 37 °C to an A600 of 1.2 and then induced with 1 mM isopropylthiogalactopyranoside. 5 h after induction, cells were harvested and resuspended in 20 mM Tris-HCl, pH 8.0, 300 mM NaCl and disrupted using a French press. Inclusion bodies were isolated from the crude cell lysate by centrifugation and washed twice with 100 mM Tris-HCl, pH 7.5, 100 mM EDTA, 10% (w/v) Triton X-100. Purified inclusion bodies were stirred for 40 min in 100 mM NaH2PO4, 10 mM Tris, pH 8.0, 8 M urea. The solution of solubilized inclusion bodies was clarified by centrifugation at 10,000 x g for 15 min at room temperature. 20 ml of solubilized LipA inclusion bodies was then diluted into 180 ml of 250 mM Tris, pH 8.0, 50 mM CaCl2, 800 mM L-arginine, 8% glycerol. Refolded protein solution was concentrated in an Amicon ultrafiltration cell (Millipore) to 80 ml. A gel filtration on a Superdex 75 column (Amersham Biosciences) in GPC buffer (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 20 mM CaCl2, 0.05% (w/v) Triton X-100) was performed with 5 ml of the concentrated refolded LipA. One major peak representing the LipA fraction was pooled and concentrated to 18 mg/ml and ~0.2% (w/v) Triton X-100 (about 3 mM).

Activity Assays—LipA was dialyzed overnight at 4 °C against buffer 20 mM Tris, 100 mM NaCl, 0.05% Triton X-100, pH 8.0, to remove excess of calcium deriving from the gel filtration buffer. After dialysis, LipA was incubated with 1, 2, and 5 mM EDTA for 1 h at room temperature. The enzymatic activity of the hydrolysis of p-nitrophenyl palmitate was determined at a concentration of 0.1 µM in 1000 µl of 25 mM Tris-HCl, pH 8.0, 10% acetonitrile, and 50 µM p-nitrophenyl palmitate at room temperature. Protein concentrations were determined by a bicinchoninic acid assay (Pierce). The absorption of the p-nitrophenolate produced by the reaction was determined at 412 nm using an Ultrospec 2100 pro (Amersham Biosciences) spectrophotometer.

Site-directed Mutagenesis—The D157A point mutation was introduced by a modified extension-overlap protocol (31) using the pET28a-LipA vector as template and the primers 5'-CGGCGCTGTGATTAACGATCTGCTAGCCGGGTTCGGGCCG-3' and 5'-CCCGGCTAGCAGATCGTTAATCACAGCGCCGATGGTATCGC-3'.

Crystallization and Data Collection—Crystals belonging to space group P321 with one molecule per asymmetric unit were obtained at 18 °C using a hanging drop vapor diffusion method. Drops were set up by mixing 3-6 µl of protein solution (18 mg/ml) with 1 µl of reservoir solution (0.1 M sodium acetate, pH 4.6, 22-28% (v/v) 2-methyl-pentane-2,4-diol) and equilibrated against 500 µl of reservoir solution at 18 °C. Hexagonal-shaped crystals were observed after 2 days and grew to an average size of 100 x 100 x 25 µm. These crystals belong to space group P321 with cell parameters of a = 115.1 Å and c = 104.6 Å. Heavy atom derivative crystals were prepared by soaking crystals in the mother solution described above containing additional 5 mM Pb(II) acetate for 30 and 1 h. After soaking, crystals were back-soaked to mother liquor containing 30% (v/v) 2-methyl-pentane-2,4-diol.

A second crystal form appeared in the same drops. These crystals belong to the space group R3 with cell constants in the hexagonal setting of a = 202.4 Å and c = 317.7 Å. This crystal form contains six molecules in the asymmetric unit. "Intermediates" between the two crystal forms, i.e. twinned crystals, were observed very frequently.

Before data collection, crystals were flash-cooled in a nitrogen stream at 110 K after raising the 2-methyl-pentane-2,4-diol concentration of the crystallization solution to 30% (v/v). Data were collected at the Swiss Light Source (Paul-Scherrer Institute, Villigen, Switzerland) using beamlines X10SA (PXII) and X06SA (PX) at 100 K employing a MAR225 CCD detector (MAR x-ray-research, Hamburg, Germany). The crystal to detector distance was 240 mm for native data and varied from 350 to 400 mm for derivatives. Oscillation angles were 0.5° per frame, and exposure times ranged from 0.5 to 1 s. Data were integrated and scaled with XDS (32) or MOSFLM (33) (Table 1).


View this table:
[in this window]
[in a new window]

 
TABLE 1
Data collection and refinement statistics

 
Structure Solution and Refinement—The structure was solved by SAD at the LI edge using Pb2+ derivatized P321 crystals. 6 heavy atom positions were found using the program SHELXD (34). Heavy occupancies were initially low, and because Pb2+ soaking damaged the crystals after some time, two very different soak times were employed to get the optimal trade-off for occupancy and diffraction. Phases were computed with SHARP (35) employing both derivatives, making use of the different occupancies. This resulted in a figure-of-merit of 0.47 and 0.14 for acentric and centric reflections, respectively. Phases were extended by solvent-flipping using SOLOMON (36), and automated model building was done by ArpWarp (37). Refinement was carried out by using REFMAC (38), and the model was completed and corrected using COOT (39). The rhombohedral structure was solved by molecular replacement employing the program PHASER (40, 41). Non-crystallographic symmetry restraints in the rhombohedral crystal form led to an increase in Rfree and were, therefore, not applied. Most figures were prepared using PyMol (Delano Scientific LLC, Palo Alto, CA).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Overall Structure
The structure of LipA was determined and refined in two crystal forms at 2.0 and 1.8 Å of resolution (Table 1). The two crystal forms grew under the same conditions. Virtually all amino acids are defined in the electron density map in both crystal forms. The seven crystallographically independent molecules totally present in the two crystal forms showed no significant deviations. The root mean square pairwise difference between the structures is 0.366 and 0.451 Å for backbone atoms and all protein atoms, respectively, whereas the root mean square difference from the mean structure is 0.240 and 0.295 Å for backbone atoms and all protein atoms, respectively.

LipA forms an ellipsoid-shaped molecule with overall dimensions of ~80 x 45 x 30 Å (Fig. 1); 8 Ca2+ ions were identified per molecule. The N-terminal domain comprising amino acids 1-320 (supplemental Fig. S1) shows a modified {alpha}/beta hydrolase fold (supplemental Fig. S2). Compared with the canonical fold, strand beta1 is split, beta3 and {alpha}A are missing, and {alpha}D has been replaced by a loop (supplemental Fig. S2). Furthermore, the eight beta strands are now split into a six-stranded mixed and a two-stranded parallel sheet.

A DALI search (42) was performed, revealing significant similarity of S. marcescens LipA to the fungal Thermomyces lanuginosa lipase (Z-score 15), whereas family I.1 and I.2 lipases proved to be much more distantly related (Z-score 3.8 for P. aeruginosa lipase). Hence, S. marcescens LipA resembles more closely eukaryotic than prokaryotic lipases (see supplemental Table S1).

Comparison to the most similar lipase structure from T. lanuginosa (PDB entries 1EIN and 1DT3) (43) revealed a number of large insertions in LipA, most notably amino acids 33-74, which form an{alpha}-helix hairpin, i.e. two antiparallel helices connected by a short loop. This element is located at one side of the active site cleft (Figs. 2 and 3A). At residue 343 the polypeptide chain leaves the lipase domain and enters the first beta-roll domain at amino acid 369. After 2.5 turns of the beta-roll, at residue 417, the polypeptide chain winds through an antiparallel beta-structure which extends the first beta-roll domain. Eventually, the secondbeta-roll domain starts at residue 489. This domain is displaced laterally from the major long axis of the molecule and packs to the first beta-roll as well as to the antiparallel beta structure succeeding it. The interface is hydrophobic, consisting mainly of leucines and aromatic residues. After 4.5 turns the polypeptide chain extends into an antiparallel beta structure enlarging the second beta-roll domain and placing the C terminus in the neighborhood of the N terminus. This last bit of the structure is very similar to the C-terminal segments of the structurally characterized beta-roll domain proteins, namely the serralysins.


Figure 1
View larger version (50K):
[in this window]
[in a new window]

 
FIGURE 1.
Overall fold of LipA as seen by two approximately orthogonal views. The polypeptide chain is rainbow-colored from blue (N terminus) to red (C terminus). Calcium ions are shown as dark spheres, and the catalytic triad are shown as stick representations. The putative lid helix {alpha}6 is colored in cyan, the first beta-roll domain is in yellow, and the second in red.

 


Figure 2
View larger version (49K):
[in this window]
[in a new window]

 
FIGURE 2.
Stereo picture of the lipase domain, overlaid with T. lanuginosa lipase. S. marcescens LipA is shown in magenta, and the closed and open conformations of T. lanuginosa lipase are in yellow and cyan, respectively. The catalytic triad is shown as sticks. The view is down the active site cleft. The {alpha}-helical hairpin is at the left front. The essential Ca2+ is indicated as Ca1. The lid is labeled.

 
Active Site
Catalytic Triad—The active site of lipases is defined by a canonical catalytic triad, which in LipA consists of Ser207, Asp256, and His314. These residues superimpose quite well with the corresponding amino acids from other lipases, e.g. for T. lanuginosa or P. aeruginosa the average distance difference is 0.5 and 1.5 Å, respectively.

Lid Structures—Inspection of the lipase active site cleft and comparison with structures in closed and open conformation from the fungus T. lanuginosa (PDB entries 1EIN and 1DT3 (43)) shows that S. marcescens LipA is in the open conformation in both crystal forms (Figs. 2 and 3) and identifies helix {alpha}6 (supplemental Fig. S1) as lid helix. This lid, an {alpha}-helical surface-exposed segment, which presents a very hydrophobic face toward the active site cleft, is characteristic for many lipases and explains interfacial activation; it is assumed that this hydrophobic patch interacts with a micellar substrate surface (Fig. 3A) and opens the active site. Interestingly, in LipA the putative lid helix is anchored in its position by a Ca2+ ion (termed Ca1), which is coordinated by aspartic acids 153 (monodentate) and 157 (bidentate), the carbonyl oxygens of Thr118 and Ser144, and the side chain of Gln120 (Fig. 3B). The coordination sphere is completed by a water molecule. This binding site is strongly conserved in lipases of family I.3 but absent in the structurally similar T. lanuginosa lipase. The calcium ion is deeply buried and at the opposite site of the active site cleft compared with the Ca2+ ions found in lipases from P. aeruginosa (PDB entry 1EX9) (44) and Pseudomonas cepacia (PDB entry 1OIL) (45). For the homologous Pseudomonas sp. MIS38 lipase it was shown that calcium is essential for activity, since dialysis against calcium-free buffer reduced the activity by about 75% and dialysis against EDTA abolishes activity completely (46). Therefore, we have determined the influence of EDTA on the activity of S. marcescens LipA (supplemental Fig. S3), showing that calcium is strictly required. Mutation of Asp157 to alanine abolished activity completely even in the presence of 20 mM Ca2+ (data not shown). Another striking feature of S. marcescens lipase is the helix hairpin mentioned before, comprising amino acids 33-74 (Figs. 2 and 3). This element presents a conspicuous hydrophobic surface to the aqueous medium and may well act as a second lid.

The Parallel beta-Roll Domains
The first beta-roll domain spans residues 368-418 and contains five GGXGXDXUX motifs. These conserved sequences are somewhat degenerated, in particular at the beginning and at the end of the motif, like 374GSDGNDLIK and 410GGKGHNIFD, where the second glycine and the aspartic acid of the consensus sequence are mutated, respectively. Consequently, there are only three calcium ions bound to this segment of the polypeptide chain because the sixth nine-residue motif is missing, and hence, the calcium binding site is incomplete.


Figure 3
View larger version (51K):
[in this window]
[in a new window]

 
FIGURE 3.
Close-up of the active site. A, semi-transparent surface representation showing nonpolar amino acids in orange and polar ones in cyan. The catalytic triad is shown as sticks with carbons in gray, nitrogens in blue, and oxygens in red. The orientation is similar to the one in Fig. 2. B, calcium coordination by amino acids from the lid helix. The lid helix is shown in cyan.

 


Figure 4
View larger version (50K):
[in this window]
[in a new window]

 
FIGURE 4.
Stereo view along the second beta-roll domain. Carbons are shown in green, oxygens in red, and nitrogens in blue.Ca2+ is shown as silver balls. Compare the more irregular bottom part with the nearly perfectly aligned motifs on the top, leading to an asymmetric Ca2+ distribution. The inserted Ala519 is labeled.

 
The second beta-roll domain spans residues 489-564 and possesses eight nine-residue motifs. Interestingly, every other of these motifs is mutated in such a way that the aspartic acid at position 6 of the nine-residue motif is missing. As a consequence, only one side of this beta-roll binds Ca2+ ions (Fig. 1 and Fig. 4). In the lower part, two water molecules are found. Insertions occur here inside and between the nine-residue motifs. For example, the insertion of an alanine 517GHAGGNLTFV occurs in the fourth motif, which places the leucine at the position 6, where normally the canonical aspartate resides. Two residues are inserted between the sixth and seventh motif 536GVGNGNTFLFSGDFGRDQLY. These observations indicate that repetitive amino acid sequence motifs may appear interrupted in the tertiary structure of the respective protein making it difficult to determine by counting the exact number of repeats.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
We have determined for the first time the atomic structure of a lipase belonging to family I.3. As expected, this enzyme consists of an N-terminal lipase domain and a C-terminal RTX domain involved in secretion of this enzyme. Additionally, our high resolution structure revealed several unusual and interesting features that deserve a more detailed discussion.

A New Type of Ca2+-dependent LipaseS. marcescens LipA possess an N-terminal {alpha}/beta hydrolase domain with some peculiar features. It is a calcium-dependent lipase for which interfacial activation has not been demonstrated yet. In the structure presented here, this lipase exhibits the open conformation that may have resulted from the presence of detergent in the crystallization medium, although the electron density map does not indicate the presence of detergent molecules. As a novel feature within microbial lipases, we have identified a Ca2+ ion, which binds the putative lid helix and is, therefore, crucial for enzymatic activity. Consequently, treatment with EDTA resulted in inactivation of LipA.

Besides the Ca2+ ion discussed above, seven additional calcium ions were identified; six bind to the GGXGXDXUX motifs and a further one (designated Ca2 in Figs. 2 and 3) is coordinated by the side chains of Glu254 (monodentate), Asp276 (bidentate), Asn285, the carbonyl O of Asn284, and two water molecules. This site is also strongly conserved; however, it is located remote from the active site, and its function remains elusive. Calcium ions bound within beta-roll domains are usually too tightly bound to be removed by dialysis or even by chelators (24, 47). Hence, Ca1 (Fig. 2) must be the essential Ca2+ ion, which is bound to the lid helix, and its removal will result in a permanent closure or even the complete distortion of the active site cleft. The inactivity of the D157A mutant strongly corroborates this hypothesis.

The Parallel beta-Roll as Intramolecular Chaperone—The structure of S. marcescens lipase revealed a novel and unique feature that we have termed "beta-roll sandwich" consisting of tandem repeats split into two groups and separated by a 70-residue spacer. The first beta-roll domain is located at a position equivalent to the serralysin-type metalloproteases, whereas the second one, which is unique for S. marcescens lipase, packs from the side tightly against the first domain and other parts of the molecule. The tandem repeats, which separate the C-terminal secretion signal from the catalytic part of the molecule, consist mainly of highly hydrophilic amino acids, thus making them soluble even in the absence of calcium, where they adopt a random coil structure (24).

This has implications for the translocation mechanism and folding of the passenger protein; contrary to T2SS, secretion by T1SS is independent of chaperones, with the exception of HasA, the Serratia marcescens heme binding protein (48, 49), which is also the only one not to possess a tandem repeat domain. HasA secretion is SecB-dependent. This cytoplasmic chaperone possibly prevents spontaneous folding of HasA, and folded HasA inhibits its own secretion (50).

The absence of chaperones poses a 2-fold challenge for the passenger protein; first, it must not fold into its native structure inside the cell because this would block at least its passage through the outer membrane protein tunnel (e.g. TolC) since crystallographic studies on TolC revealed a channel of only about 30 Å in width (51). Second, because the passenger protein is translocated into the chaperone-free external medium, it must be able to fold efficiently into its native conformation. Consequently, a characteristic feature of T1SS passenger proteins is the absence of disulfide bonds, presumably because there are no disulfide-bond isomerases or similar helper proteins present that could rescue "scrambled" proteins. It is tempting to speculate that the parallel beta-roll structure may act as an intramolecular chaperone that keeps the polypeptide chain unfolded in the cytoplasm where Ca2+ concentrations are about 0.1 µM, although in the external medium with Ca2+ concentrations in the mM range the glycine-rich repeats would fold spontaneously (24, 25, 47) and provide a nucleus for the folding of the entire polypeptide chain.

Such a chaperone-like function would imply that the number of beta-roll domains positively correlates with the size of the respective passenger proteins. Furthermore, this assumption is nicely supported by our recent finding that S. marcescens LipA can be autodisplayed on the surface of E. coli cells by fusing it to an autotransporter protein from P. aeruginosa. The autotransporter domain efficiently inserts into the bacterial outer membrane with the lipase domain facing the extracellular medium, where it folds into its enzymatically active conformation (52).

Studies on the homologous Pseudomonas sp. MIS38 lipase have shown that partial or complete knock-out of the tandem repeats leads to strongly reduced protein and secretion levels. Furthermore, knock-out of all repeats resulted in a virtually inactive enzyme (53). The intracellular stability is also affected being about 600 times lower than that of the wild type. This can be explained by rapid degradation of non-secreted protein rather than by a lower stability because a mutant lacking just the 19 C-terminal amino acids accumulates to an amount 100 times less than the wild type.

Another new and unexpected feature revealed by the structure of S. marcescens LipA is related to the second set of tandem repeats. These repeats do not simply extend the first beta-roll domain along the helical axis but pack laterally against it. This appears to be a general feature of all RTX proteins possessing more than eight nine-residue motifs, e.g. E. coli hemolysin (28 repeats) or Bordetella pertussis cyclolysin, where the ~40 repeats come in blocks separated by linker sequences. In this way the beta-roll domains become integral parts of the whole structure and can act as folding nuclei, stabilizing different parts of the catalytic N-terminal domains. The larger those N-terminal domains, the more beta-rolls are needed. The Ca2+-induced folding of the N-terminal passenger domains by the beta-roll has been demonstrated directly in some cases (47, 54, 55).


    FOOTNOTES
 
The atomic coordinates and structure factors (code 2QUA and 2QUB) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* This work has been supported by the Swiss National Science Foundation and by the Hochschulstiftung der Universität Bern. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental material. Back

1 To whom correspondence may be addressed. Tel.: 49-2461-613716; Fax: 49-2461-612490; E-mail: karl-erich.jaeger{at}fz-juelich.de. 2 To whom correspondence may be addressed. Tel.: 41-31-631-4320; Fax: 41-31-6314887; E-mail: ulrich.baumann{at}ibc.unibe.ch.

3 The abbreviations used are: T2SS, type 2 secretion system; T1SS, type 1 secretion system; RTX, repeats in toxins. Back


    ACKNOWLEDGMENTS
 
We are grateful to Santina Russo, Clemens Schulze-Briese, and Takashi Tomizaki from the Swiss Light Source, Paul-Scherrer-Institute, Villigen, for help during data collection. Furthermore, we want to thank Michael Werner for developing a protocol for S. marcescens lipase purification and refolding. Ulrich K. Winkler, professor emeritus at Ruhr-University Bochum, Germany, is greatly acknowledged for encouragement and support during the early days of research on Serratia marcescens lipase.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Jaeger, K. E., Ransac, S., Dijkstra, B. W., Colson, C., van Heuvel, M., and Misset, O. (1994) FEMS Microbiol. Rev. 15, 29-63[CrossRef][Medline] [Order article via Infotrieve]
  2. Jaeger, K. E., Dijkstra, B. W., and Reetz, M. T. (1999) Annu. Rev. Microbiol. 53, 315-351[CrossRef][Medline] [Order article via Infotrieve]
  3. Jaeger, K. E., and Eggert, T. (2002) Curr. Opin. Biotechnol. 13, 390-397[CrossRef][Medline] [Order article via Infotrieve]
  4. Reetz, M. T., and Jaeger, K. E. (2000) Chem. Eur. J. 6, 407-412[CrossRef]
  5. Reetz, M. T., Zonta, A., Schimossek, K., Liebeton, K., and Jaeger, K.-E. (1997) Angew. Chem. Int. Ed. Engl. 36, 2830-2832[CrossRef]
  6. Liebeton, K., Zonta, A., Schimossek, K., Nardini, M., Lang, D., Dijkstra, B. W., Reetz, M. T., and Jaeger, K. E. (2000) Chem. Biol. 7, 709-718[CrossRef][Medline] [Order article via Infotrieve]
  7. Reetz, M. T., Puls, M., Carballeira, J. D., Vogel, A., Jaeger, K. E., Eggert, T., Thiel, W., Bocola, M., and Otte, N. (2007) Chembiochem 8, 106-112[CrossRef][Medline] [Order article via Infotrieve]
  8. Sarda, L., and Desnuelle, P. (1958) Biochim. Biophys. Acta. 30, 513-521[Medline] [Order article via Infotrieve]
  9. Brzozowski, A. M., Derewenda, U., Derewenda, Z. S., Dodson, G. G., Lawson, D. M., Turkenburg, J. P., Bjorkling, F., Huge-Jensen, B., Patkar, S. A., and Thim, L. (1991) Nature 351, 491-494[CrossRef][Medline] [Order article via Infotrieve]
  10. Cygler, M., and Schrag, J. D. (1997) Methods Enzymol. 284, 3-27[CrossRef][Medline] [Order article via Infotrieve]
  11. Verger, R. (1997) Trends Biotechnol. 15, 32-38[CrossRef]
  12. Arpigny, J. L., and Jaeger, K. E. (1999) Biochem. J. 343, 177-183[CrossRef][Medline] [Order article via Infotrieve]
  13. Schrag, J. D., and Cygler, M. (1997) Methods Enzymol. 284, 85-107[Medline] [Order article via Infotrieve]
  14. Filloux, A. (2004) Biochim. Biophys. Acta 1694, 163-179[Medline] [Order article via Infotrieve]
  15. Johnson, T. L., Abendroth, J., Hol, W. G., and Sandkvist, M. (2006) FEMS Microbiol. Lett. 255, 175-186[CrossRef][Medline] [Order article via Infotrieve]
  16. Wandersman, C. (1992) Trends Genet. 8, 317-322[Medline] [Order article via Infotrieve]
  17. Angkawidjaja, C., and Kanaya, S. (2006) Cell. Mol. Life Sci. 63, 2804-2817[CrossRef][Medline] [Order article via Infotrieve]
  18. Thanassi, D. G., and Hultgren, S. J. (2000) Curr. Opin. Cell Biol. 12, 420-430[CrossRef][Medline] [Order article via Infotrieve]
  19. Gentschev, I., Dietrich, G., and Goebel, W. (2002) Trends Microbiol. 10, 39-45[CrossRef][Medline] [Order article via Infotrieve]
  20. Welch, R. A. (2001) Curr. Top. Microbiol. Immunol. 257, 85-111[Medline] [Order article via Infotrieve]
  21. Baumann, U. (1994) J. Mol. Biol. 242, 244-251[CrossRef][Medline] [Order article via Infotrieve]
  22. Baumann, U., Wu, S., Flaherty, K. M., and McKay, D. B. (1993) EMBO J. 12, 3357-3364[Medline] [Order article via Infotrieve]
  23. Hege, T., and Baumann, U. (2001) J. Mol. Biol. 314, 187-193[CrossRef][Medline] [Order article via Infotrieve]
  24. Lilie, H., Haehnel, W., Rudolph, R., and Baumann, U. (2000) FEBS Lett. 470, 173-177[CrossRef][Medline] [Order article via Infotrieve]
  25. Rose, T., Sebo, P., Bellalou, J., and Ladant, D. (1995) J. Biol. Chem. 270, 26370-26376[Abstract/Free Full Text]
  26. Winkler, U. K., and Stuckmann, M. (1979) J. Bacteriol. 138, 663-670[Abstract/Free Full Text]
  27. Li, X., Tetling, S., Winkler, U. K., Jaeger, K. E., and Benedik, M. J. (1995) Appl. Environ. Microbiol. 61, 2674-2680[Abstract]
  28. Matsumae, H., Furui, M., and Shibatani, T. (1993) J. Ferment. Bioeng. 93, 93-98
  29. Liese, A., Seelbach, K., and Wandrey, C. (eds) (2006) Industrial Biotransformations, Wiley-VCH, Weinheim, Germany
  30. Angkawidjaja, C., You, D. J., Matsumura, H., Koga, Y., Takano, K., and Kanaya, S. (2007) Acta Crystallogr. F Struct. Biol. Crystalliz. Comm. 63, 187-189[CrossRef]
  31. Zheng, L., Baumann, U., and Reymond, J. L. (2004) Nucleic Acids Res. 32, e115[Abstract/Free Full Text]
  32. Kabsch, W. (2001) in International Tables for Crystallography (Rossmann, M. G., and Arnold, E., eds) Vol. F, Kluwer Academic Publisher, Dordrecht, Germany
  33. Leslie, A. G. W. (1996) Joint CCP4/ESF-EACBM Newsletter Protein Crystallogr. 32, 7-8
  34. Schneider, T. R., and Sheldrick, G. M. (2002) Acta Crystallogr. D Biol. Crystallogr. 58, 1772-1779[CrossRef][Medline] [Order article via Infotrieve]
  35. Bricogne, G., Vonrhein, C., Flensburg, C., Schiltz, M., and Paciorek, W. (2003) Acta Crystallogr. D Biol. Crystallogr. 59, 2023-2030[CrossRef][Medline] [Order article via Infotrieve]
  36. Abrahams, J. P., and Leslie, A. G. (1996) Acta Crystallogr. D Biol. Crystallogr. 52, 30-42[CrossRef][Medline] [Order article via Infotrieve]
  37. Perrakis, A., Morris, R., and Lamzin, V. S. (1999) Nat. Struct. Biol. 6, 458-463[CrossRef][Medline] [Order article via Infotrieve]
  38. Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997) Acta Crystallogr. D Biol. Crystallogr. 53, 240-255[CrossRef][Medline] [Order article via Infotrieve]
  39. Emsley, P., and Cowtan, K. (2004) Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132[CrossRef][Medline] [Order article via Infotrieve]
  40. McCoy, A. J., Grosse-Kunstleve, R. W., Storoni, L. C., and Read, R. J. (2005) Acta Crystallogr. D Biol. Crystallogr. 61, 458-464[CrossRef][Medline] [Order article via Infotrieve]
  41. Storoni, L. C., McCoy, A. J., and Read, R. J. (2004) Acta Crystallogr. D Biol. Crystallogr. 60, 432-438[CrossRef][Medline] [Order article via Infotrieve]
  42. Holm, L., and Sander, C. (1993) J. Mol. Biol. 233, 123-138[CrossRef][Medline] [Order article via Infotrieve]
  43. Brzozowski, A. M., Savage, H., Verma, C. S., Turkenburg, J. P., Lawson, D. M., Svendsen, A., and Patkar, S. (2000) Biochemistry 39, 15071-15082[CrossRef][Medline] [Order article via Infotrieve]
  44. Nardini, M., Lang, D. A., Liebeton, K., Jaeger, K. E., and Dijkstra, B. W. (2000) J. Biol. Chem. 275, 31219-31225[Abstract/Free Full Text]
  45. Kim, K. K., Song, H. K., Shin, D. H., Hwang, K. Y., and Suh, S. W. (1997) Structure 5, 173-185[Medline] [Order article via Infotrieve]
  46. Angkawidjaja, C., Kuwahara, K., Omori, K., Koga, Y., Takano, K., and Kanaya, S. (2006) Protein Eng. Des. Sel. 19, 337-343[Abstract/Free Full Text]
  47. Bauche, C., Chenal, A., Knapp, O., Bodenreider, C., Benz, R., Chaffotte, A., and Ladant, D. (2006) J. Biol. Chem. 281, 16914-16926[Abstract/Free Full Text]
  48. Letoffe, S., Ghigo, J. M., and Wandersman, C. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 9876-9880[Abstract/Free Full Text]
  49. Letoffe, S., Ghigo, J. M., and Wandersman, C. (1994) J. Bacteriol. 176, 5372-5377[Abstract/Free Full Text]
  50. Debarbieux, L., and Wandersman, C. (2001) EMBO J. 20, 4657-4663[CrossRef][Medline] [Order article via Infotrieve]
  51. Koronakis, V., Sharff, A., Koronakis, E., Luisi, B., and Hughes, C. (2000) Nature 405, 914-919[CrossRef][Medline] [Order article via Infotrieve]
  52. Becker, S., Theile, S., Heppeler, N., Michalczyk, A., Wentzel, A., Wilhelm, S., Jaeger, K. E., and Kolmar, H. (2005) FEBS Lett. 579, 1177-1182[CrossRef][Medline] [Order article via Infotrieve]
  53. Kwon, H. J., Haruki, M., Morikawa, M., Omori, K., and Kanaya, S. (2002) J. Biosci. Bioeng. 93, 157-164[CrossRef][Medline] [Order article via Infotrieve]
  54. Angkawidjaja, C., Paul, A., Koga, Y., Takano, K., and Kanaya, S. (2005) FEBS Lett. 579, 4707-4712[Medline] [Order article via Infotrieve]
  55. Miyajima, Y., Hata, Y., Fukushima, J., Kawamoto, S., Okuda, K., Shibano, Y., and Morihara, K. (1998) J. Biochem. (Tokyo) 123, 24-27[Abstract/Free Full Text]
  56. Kleywegt, G. J., and Jones, T. A. (1996) Structure 4, 1395-1400[Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/43/31477    most recent
M704942200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meier, R.
Right arrow Articles by Baumann, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meier, R.
Right arrow Articles by Baumann, U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.